Korlym (Corcept Therapeutics Inc)


Welcome to the PulseAid listing for the Korlym drug offered from Corcept Therapeutics Inc. This Progestational Hormone Receptor Antagonists [MoA],Progestin Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Corcept Therapeutics Inc
NON-PROPRIETARY NAME: Mifepristone
SUBSTANCE NAME: MIFEPRISTONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Progestational Hormone Receptor Antagonists [MoA],Progestin Antagonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-02-17
END MARKETING DATE: 0000-00-00


Korlym HUMAN PRESCRIPTION DRUG Details:

Item DescriptionKorlym from Corcept Therapeutics Inc
LABELER NAME: Corcept Therapeutics Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/1)
START MARKETING DATE: 2012-02-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76346-073_2c2f37c5-3df0-4f90-a2c9-b8a62012bdf8
PRODUCT NDC: 76346-073
APPLICATION NUMBER: NDA202107

Other MIFEPRISTONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Corcept Therapeutics IncKorlym